Back
International Biosecurity and Biosafety Initiative for Science (IBBIS) - Program Overview
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Nuclear Threat Initiative
Relevant to AI safety discussions on dual-use technology governance; IBBIS offers a biosecurity governance model that parallels challenges in regulating dual-use AI capabilities and establishing international norms for dangerous emerging technologies.
Metadata
Importance: 42/100homepage
Summary
IBBIS is an independent organization established under the Nuclear Threat Initiative (NTI) to strengthen global biosecurity norms and develop practical tools to reduce risks from accidental or deliberate misuse of modern bioscience and biotechnology. The initiative addresses governance gaps exacerbated by COVID-19, including proliferation of pathogen research and new high-containment labs. It works to safeguard dual-use bioscience while enabling beneficial research to advance.
Key Points
- •Addresses dual-use risks from rapid bioscience advances that governments have struggled to adequately oversee, with potentially catastrophic misuse consequences.
- •Operates as an independent organization focused on developing innovative biosecurity tools, norms, and incentives at a global scale.
- •COVID-19 accelerated risks by spurring pathogen research proliferation and new high-containment lab construction worldwide.
- •Combines policy expertise with practical tool development to reduce both accidental misuse and deliberate abuse of biotechnology.
- •Part of NTI's broader biological threat reduction portfolio, linked to the Biosecurity Innovation and Risk Reduction Initiative.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| NTI | bio (Nuclear Threat Initiative - Biological Program) | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 7, 202614 KB
International Biosecurity and Biosafety Initiative for Science (IBBIS)
Close
International Biosecurity and Biosafety Initiative for Science (IBBIS)
Biological
Safeguarding modern bioscience and biotechnology so it can advance and flourish safely and responsibly
Challenge
Rapid advances in bioscience offer great promise but can increase risks of accidental or deliberate misuse, with potentially catastrophic consequences. Governments have not been able to provide adequate oversight.
Action
Establish an independent organization dedicated to strengthening global biosecurity norms and developing innovative tools and incentives to uphold them.
Results
Active development of stronger biosecurity norms and practical tools that reduce the risk of accidental misuse or deliberate abuse of modern bioscience and biotechnology.
m">
Details
Project Staff
Piers Millett, Ph.D.
Executive Director, International Biosecurity & Biosafety Initiative for Science (IBBIS)
Jaime M. Yassif, PhD
Senior Advisor
Hayley Severance
Deputy Vice President, Global Biological Policy and Programs
Aparupa Sengupta, PhD, RBP
Rachel Staley Grant
Senior Director, Global Biological Policy and Programs
Links & Downloads
International Biosecurity and Biosafety Initiative for Science (IBBIS)
Biosecurity Innovation and Risk Reduction Initiative
Preventing Global Catastrophic Biological Risks
Taking Action to Safeguard Bioscience and Protect Against Future Global Biological Risks
The Hill | We must take action to guard against future global biological risks
Bioscience and biotechnology advances are vital for fighting disease, protecting the environment, and promoting economic development. However, these same innovations can also pose unique challenges—increasing the risks of accidental misuse or deliberate abuse with potentially catastrophic consequences.
These underlying risks are not new, but they have been exacerbated by COVID-19, which has led to the proliferation of research into pathogens with pandemic potential and the establishment of new high-containment labs around the world to house this work. While this research can have significant value, some of it poses dual-use risks. COVID-19 also has demonstrated that biological events have the potential to cause severe human and economic loss on a global scale, which could inspire malevolent actors to exploit pathogens and biotechnology to cause harm. This threat is of growing concern as the technical barriers to manipulating biological organisms continue to fall.
Governments are key to safeguarding the life sciences, bu
... (truncated, 14 KB total)Resource ID:
2cbf3ff302a9a246 | Stable ID: sid_gAz88Xl7In